This page shows the details of why an item matched the keywords from your search.
Item Type | Name |
Concept
|
Leukemia, Myeloid
|
Concept
|
Leukemia, Myeloid, Acute
|
Academic Article
|
Recent insights into the mechanisms of myeloid leukemogenesis in Down syndrome.
|
Academic Article
|
High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).
|
Academic Article
|
MiR-495 is a tumor-suppressor microRNA down-regulated in MLL-rearranged leukemia.
|
Academic Article
|
An integrated genomic approach to the assessment and treatment of acute myeloid leukemia.
|
Academic Article
|
TET1 plays an essential oncogenic role in MLL-rearranged leukemia.
|
Academic Article
|
miR-9 is an essential oncogenic microRNA specifically overexpressed in mixed lineage leukemia-rearranged leukemia.
|
Academic Article
|
Overexpression and knockout of miR-126 both promote leukemogenesis.
|
Academic Article
|
PBX3 and MEIS1 Cooperate in Hematopoietic Cells to Drive Acute Myeloid Leukemias Characterized by a Core Transcriptome of the MLL-Rearranged Disease.
|
Academic Article
|
Identification of MLL-fusion/MYC?miR-26?TET1 signaling circuit in MLL-rearranged leukemia.
|
Academic Article
|
miR-22 has a potent anti-tumour role with therapeutic potential in acute myeloid leukaemia.
|
Academic Article
|
Eradication of Acute Myeloid Leukemia with FLT3 Ligand-Targeted miR-150 Nanoparticles.
|
Academic Article
|
Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis.
|
Academic Article
|
FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase.
|
Academic Article
|
LKB1/STK11 Is a Tumor Suppressor in the Progression of Myeloproliferative Neoplasms.
|
Academic Article
|
Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation.
|
Academic Article
|
Therapy-related myeloid neoplasms with normal karyotype show distinct genomic and clinical characteristics compared to their counterparts with abnormal karyotype.
|
Academic Article
|
Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors.
|
Academic Article
|
NPM1 exon 5 mutations in acute myeloid leukemia: Implications in diagnosis and minimal residual monitoring.
|
Academic Article
|
Oncogenic RAS promotes leukemic transformation of CUX1-deficient cells.
|
Academic Article
|
The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition.
|
Academic Article
|
Durable responses in acute lymphoblastic leukaemia with the use of FLT3 and IDH inhibitors.
|